KKR Gets Minimal Acceptances as Part of $2.29 Billion Assura Takeover Bid

Dow Jones
Jul 14, 2025
 

By Adam Whittaker

 

Private-equity firm KKR said it has received acceptances representing approximately 0.0084% of U.K. healthcare-property investor Assura's share capital as part of its 1.70 billion-pound ($2.29 billion) takeover.

KKR said Monday that as of the end of last week, it owned 164.8 million of Assura shares, or 5.07% of its issued capital. Its offer is open until Aug. 12, and it encouraged Assura shareholders to accept it as soon as possible.

KKR and Primary Health Properties have been bidding to buy Assura in recent months. Assura and PHP are two of the largest listed real-estate investment trusts that specialize in healthcare facilities across the U.K.

On June 11 KKR raised its offer to buy Assura to a best and final price of 52.1 pence in cash a share, including dividends, from an initial price of 49.4 pence a share on April 9.

Assura subsequently agreed to a 1.79 billion-pound share and cash takeover from PHP on June 23.

In early July, the U.K. markets watchdog said it was considering whether PHP's acquisition of Assura would lessen competition in the healthcare-property sector as part of its information-gathering process. It said that no formal investigation has been opened and it invited comments before July 18.

 

Write to Adam Whittaker at adam.whittaker@wsj.com

 

(END) Dow Jones Newswires

July 14, 2025 02:54 ET (06:54 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10